SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-18-003668
Filing Date
2018-05-14
Accepted
2018-05-14 08:50:00
Documents
56
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s109882_10q.htm 10-Q 261098
2 EXHIBIT 31.1 s109882_ex31-1.htm EX-31.1 13303
3 EXHIBIT 31.2 s109882_ex31-2.htm EX-31.2 13103
4 EXHIBIT 32.1 s109882_ex32-1.htm EX-32.1 4100
5 EXHIBIT 32.2 s109882_ex32-2.htm EX-32.2 6867
  Complete submission text file 0001615774-18-003668.txt   1972863

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE atos-20180331.xml EX-101.INS 292420
7 XBRL SCHEMA FILE atos-20180331.xsd EX-101.SCH 28454
8 XBRL CALCULATION FILE atos-20180331_cal.xml EX-101.CAL 38477
9 XBRL DEFINITION FILE atos-20180331_def.xml EX-101.DEF 74678
10 XBRL LABEL FILE atos-20180331_lab.xml EX-101.LAB 203950
11 XBRL PRESENTATION FILE atos-20180331_pre.xml EX-101.PRE 157520
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 18828817
SIC: 2834 Pharmaceutical Preparations